Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 12—December 2014

MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983–1997

Marcel A. Müller1Comments to Author , Victor Max Corman1, Joerg Jores, Benjamin Meyer, Mario Younan, Anne M. Liljander, Berend-Jan Bosch, Erik Lattwein, Mosaad Hilali, Bakri E. Musa, Set Bornstein, and Sung Sup Park
Author affiliations: University of Bonn Medical Centre, Bonn, Germany (M.A. Müller, V.M. Corman, B. Meyer, C. Drosten); German Centre for Infection Research, Bonn (V.M. Corman); International Livestock Research Institute, Nairobi, Kenya (J. Jores, A. Liljander); Vétérinaires Sans Frontières Germany, Nairobi (M. Younan); Utrecht University, Utrecht, the Netherlands (B.-J. Bosch); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Cairo University, Giza, Egypt (M. Hilali); Ministry of Science and Communication, Khartoum, Sudan (B.E. Musa); National Veterinary Institute, Uppsala, Sweden (S. Bornstein)

Main Article

Table 1

MERS-CoV antibodies in dromedary camels from eastern Africa*

Country, date No. samples No. rELISA positive (%)† No. mNT positive (%)‡
Egypt, 1997 Jul 43 35 (81.4) 34 (79.1)
1983 Jan–Nov 25 20 (80.0) 17 (68.0)
1984 Feb–Dec 61 52 (85.2) 53 (86.9)
Sudan, 1983 Jun 60 52 (86.7) 49 (81.7)
Total 189 159 (84.1) 153 (81.0)

*MERS-CoV, Middle East respiratory syndrome coronavirus; mNT, microneutralization test; rELISA, recombinant ELISA based on the MERS-CoV subunit 1 spike protein.
†Serum was tested at a dilution of 1:100.
‡mNT for MERS-CoV was done in a microtiter plate format in duplicate at dilutions 1:80 and 1:800. Serum with reciprocal titers >80 were considered MERS-CoV antibody positive.

Main Article

1These authors contributed equally to this article.

Page created: November 19, 2014
Page updated: November 19, 2014
Page reviewed: November 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.